CytoDyn (OTC: CYDY) Receives BLA Acknowledgment Letter From the FDA
VANCOUVER, Washington, Jun 08, 2020 (GLOBE NEWSWIRE via COMTEX) — PDUFA date could be set by the FDA on July 10 CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]
